million or 11.6% due to the following reasons: Unit: Million Baht - The cash-base patients’ revenue for Q3/2018 were Baht 1,518.9 million which increased from Q3/2017 by Baht 245.3 million or 19.3% as a
Baht and the realized net profit in 2017 was consisted of gain on sales of subsidiary’s assets for 156.57 million Baht Gross Profit (Loss) The Company has a gross profit from sales of goods and services
Baht and the realized net profit in 2017 was consisted of gain on sales of subsidiary’s assets for 156.57 million Baht Gross Profit (Loss) The Company has a gross profit from sales of goods and services
country with small base of sale which has high potential for growth such as Vietnam and Myanmar while sales export to new market such as China amount to THB 195 million or equivalent to 24 million units
responsible areas and some country with small base of sale which has high potential for growth such as Vietnam and Myanmar while sales export to new market such as China amount to THB 195 million or equivalent
responsible areas and some country with small base of sale which has high potential for growth such as Vietnam and Myanmar while sales export to new market such as China amount to THB 195 million or equivalent
reserves. Analysis of Financial Positions Assets As of 30 June 2020, the Company has total assets the amount shown in the consolidated financial statements was 23,768.0 million baht, an increase from the end
held on January 4, 2018 which approved the disposal of 8 items of assets of the Company, including 16 plots of land bank on Charan Sanit Wong Road, Bangkok (“Charan Sanit Wong Project”), at a total sale
of goods sold (COGS) as mentioned. Statement of Financial Position Items As at 31st Mar, 2018 As at 31st Dec, 2017 + / (-) Current Assets 2,534.8 3,118.7 (583.9) Noncurrent Assets 3,285.4 2,425.3 860.1
the Stock Exchange of Thailand concerning the Acquisition and Disposition of Assets namely 1) the net tangible asset value basis 2) the net profit basis and 3) the total value of consideration basis